益脑心颗粒的化学成分分析与毒性评估
本研究采用UPLC-MS表征益脑心颗粒化学成分,并在小鼠和大鼠中评估急性与亚慢性毒性。结果显示含槲皮素、山奈酚等多种活性成分,在20 g/kg剂量下未见明显毒性,支持其短期安全性。
要点
- 益脑心颗粒含槲皮素、山奈酚、芦丁等黄酮与萜类成分。
- 小鼠单次口服20 g/kg及大鼠30天重复给药20 g/kg未见毒性。
- 脑氧化应激指标及肠、肝、肾、生殖器官免疫组化未见异常。
核心结论
- 益脑心颗粒在测试条件下未检测到急性或亚慢性毒性,支持其短期安全性。
研究设计与样本
- UPLC-MS表征化学成分;C57BL/6小鼠单次口服5、10、20 g/kg观察7天;SD大鼠每日口服5、10、20 g/kg连续30天。
主要发现
- UPLC-MS confirmed quercetin, kaempferol, rutin, luteolin, chlorogenic acid, rosmarinic acid and ursolic acid.
- 急性毒性:小鼠20 g/kg剂量下无死亡或治疗相关临床毒性。
- 30天重复给药:大鼠体重、摄食、器官系数、血液学与生化参数正常,未见治疗相关组织病理学病变。
- 脑氧化应激标志物(CAT、SOD、GSH、MDA)无显著治疗相关变化。
- 免疫组化显示ZO-1、AR、ER-α、α-SMA表达无改变。
临床怎么用
- 现有数据支持益脑心颗粒在20 g/kg剂量下的短期安全性,可为临床剂量选择提供参考。
局限性
- 研究仅评估短期暴露,长期安全性需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Yinaoxin granules (YNX) is a widely used Chinese herbal preparation composed of six medicinal herbs. YNX has been shown to effectively mitigate both headaches and dizziness. However, systematic investigations into its chemical basis and safety profile remain limited. Therefore, a comprehensive evaluation of the chemical constituents and toxicological profile of YNX is critical and urgent. AIM OF THE STUDY: This study aimed to characterize the chemical constituents of YNX and evaluate its toxicological safety through both acute and subacute exposure assessments. MATERIALS AND METHODS: The chemical constituents of YNX were characterized via ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). Acute toxicity was assessed in C57BL/6 mice after a single oral dose of 5, 10 or 20 g/kg with 7-day observation. Subchronic toxicity was evaluated in Sprague-Dawley rats given daily oral doses of 5, 10 or 20 g/kg for 30 days. Animals were monitored for clinical signs, body weight and food intake. At study end, hematology, serum biochemistry, organ coefficients and histopathology were performed. Targeted assays included brain oxidative-stress markers (CAT, SOD, GSH, MDA) and immunohistochemistry for ZO-1 (intestine), AR (testis), ER-α (ovary) and α-SMA (liver and kidney). RESULTS: UPLC-MS confirmed multiple bioactive constituents in YNX, including quercetin, kaempferol, rutin, luteolin, chlorogenic acid, rosmarinic acid and ursolic acid; the analytical method demonstrated satisfactory stability and reproducibility. In the acute study no mortality or treatment-related clinical toxicity was observed up to 20 g/kg. In the 30-day study, YNX-treated rats maintained normal body weight, food intake, organ coefficients, hematological and biochemical parameters, and no treatment-related histopathological lesions were observed. Brain oxidative-stress markers showed no significant treatment-related changes. Immunohistochemistry revealed no alterations in ZO-1, AR, ER-α or α-SMA expression, indicating preserved barrier integrity, reproductive receptor expression and lack of fibrogenic activation. CONCLUSION: YNX contains abundant flavonoids and terpenoids and exhibited no detectable acute or subchronic toxicity under the tested conditions. These integrated chemical and toxicological data support the short-term safety of YNX and provide a foundation for dosing guidance and further long-term safety evaluation.
引用
- Liu L, Weng J, Yue L, et al. Phytochemical profiling and toxicity assessment of Yinaoxin granules. J Ethnopharmacol. 2025. PMID: 40902812. doi:10.1016/j.jep.2025.120483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。